STMN2 and amyotrophic lateral sclerosis: Second, aggregation of TDP-43, a hallmark of most ALS (excluding SOD1-ALS), results in the reduced expression of STMN2, a key axon survival factor that inhibits SARM1-mediated axon destruction [49–52].